Please login to the form below

Not currently logged in
Email:
Password:

iPierian

This page shows the latest iPierian news and features for those working in and with pharma, biotech and healthcare.

AbbVie and C2N take tau antibody into clinic

AbbVie and C2N take tau antibody into clinic

Last year, Bristol-Myers Squibb bought into the field via a $725m deal to acquire iPierian.

Latest news

  • BMS buys Alzheimer's player iPierian in $725m deal BMS buys Alzheimer's player iPierian in $725m deal

    In addition to the tau-targeted pipeline, BMS will also tap into iPierian's expertise in disease models, which grew out of earlier work on stem cells. ... BMS has paid $175m upfront for iPierian, with the potential for additional development and

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cogora

Cogora has been a leader in healthcare publishing for over 30 years and has become one of the leading full-service...

Latest intelligence

Unlocking the potential of science and technology in the UK
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...

Infographics